Gemcitabine Plus Vinorelbine for Refractory or Relapsing Non-Hodgkin Lymphoma: Response Rate and Survival
Sally Hamdy Elsied Abd Elbary, Wael Mansour Saed, Fatma Zakaria Hussein & Ashraf fathy Barakat · Journal of Advances in Medicine and Medical Research · 2021
Background: Two chemotherapeutic agents, vinorelbine and gemcitabine, have shown encouraging early results in the treatment of heavily pre-treated relapsed or refractory lymphoma when used as single agents, with responses of between 20 and 47%. This work aimed to evaluate the rol...
Open access
Research Article
10.9734/jammr/2021/v33i2331184